ATOSSA THERAPEUTICS, INC. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| QUAY STEVEN C | President & CEO | Purchase | 11,239 | $0.88 | $9,890 | 13,898 | May 21, 2025 |
| Remmel H. Lawrence | — | Purchase | 10,000 | $0.70 | $7,000 | 10,257 | Mar 26, 2025 |
| Finn Jonathan | — | Purchase | 25,000 | $1.77 | $44,250 | 25,000 | Apr 10, 2024 |
| WEAVER GREGORY L | Former EVP, CFO, & Director | Sale | 50,000 | $0.65 | $32,500 | 55 | Nov 15, 2023 |
| WEAVER GREGORY L | EVP & CFO | Purchase | 50,000 | $0.97 | $48,500 | 50,055 | Jun 20, 2023 |
| WEAVER GREGORY L | — | Tax Withholding | 57,084 | $6.40 | $365,338 | 107,497 | Jul 2, 2021 |
| Guse Kyle | CFO, Gen Counsel and Secretary | Purchase | 8,600 | $0.34 | $2,924 | 8,600 | Nov 15, 2017 |
| Remmel H. Lawrence | — | Purchase | 2,500 | $0.63 | $1,575 | 3,126 | Apr 17, 2017 |
| Remmel H. Lawrence | — | Purchase | 1,500 | $0.33 | $495 | 10,900 | Apr 1, 2016 |
| Chen Shu-Chih | — | Purchase | 15,000 | $0.37 | $5,550 | 4,348,315 | Mar 9, 2016 |
| QUAY STEVEN C | President & CEO | Purchase | 15,000 | $0.37 | $5,550 | 4,826,858 | Mar 9, 2016 |
| QUAY STEVEN C | President & CEO | Purchase | 15,000 | $0.53 | $7,950 | 4,811,858 | Feb 16, 2016 |
| Chen Shu-Chih | — | Purchase | 15,000 | $0.53 | $7,950 | 4,333,315 | Feb 16, 2016 |
| Chen Shu-Chih | — | Purchase | 50,000 | $0.20 | $10,000 | 4,318,315 | Jan 19, 2016 |
| QUAY STEVEN C | President & CEO | Purchase | 50,000 | $0.20 | $10,000 | 4,796,858 | Jan 19, 2016 |
| Remmel H. Lawrence | — | Purchase | 5,400 | $1.30 | $7,020 | 9,400 | Jun 12, 2015 |
| WEAVER GREGORY L | — | Disposition | 24,510 | — | — | — | May 6, 2014 |
| Steinhart Richard I | — | Disposition | 22,728 | — | — | — | May 6, 2014 |
| Steinhart Richard I | — | Award / Grant | 22,728 | — | — | 22,728 | Mar 1, 2014 |
| WEAVER GREGORY L | — | Purchase | 10,000 | $2.58 | $25,800 | 34,510 | Nov 21, 2013 |
| WEAVER GREGORY L | — | Award / Grant | 24,510 | — | — | 24,510 | Oct 10, 2013 |
| QUAY STEVEN C | CEO | Sale | 7,265 | $5.66 | $41,120 | 4,268,315 | Oct 1, 2013 |
| Chen Shu-Chih | Chief Scientific Officer | Sale | 7,265 | $5.66 | $41,120 | 4,268,315 | Oct 1, 2013 |
| QUAY STEVEN C | Chief Executive Officer | Gift | 1,000 | — | — | 583,543 | Jul 18, 2013 |
| Chen Shu-Chih | Chief Scientific Officer | Gift | 5,000 | — | — | 478,543 | Jul 18, 2013 |
| CROSS ALEXANDER D | — | Purchase | 500 | $5.49 | $2,745 | 88,866 | May 15, 2013 |
| Remmel H. Lawrence | — | Purchase | 1,600 | $4.20 | $6,720 | 2,000 | Jan 8, 2013 |